However, in HCC progenitor exhausted CD8+ T cells have been demonstrated ex vivo by PD1int, TCF-1+, TOXlo expression, providing a potential reservoir for SLAMF6-mediated ICS to reinvigorate anti-tumour immunity (68). The gene discussed is CD8A; the disease is hepatocellular carcinoma.